NUV-1511
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NUV-1511, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]